Search Results - "Sauerbruch, T"

Mechanisms of extrahepatic vasodilation in portal hypertension by Hennenberg, M, Trebicka, J, Sauerbruch, T, Heller, J

“…In liver cirrhosis, abnormal persistent extrahepatic vasodilation leads to hyperdynamic circulatory dysfunction which essentially contributes to portal…”
Get more information

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C by Nattermann, J, Feldmann, G, Ahlenstiel, G, Langhans, B, Sauerbruch, T, Spengler, U

“…Introduction: Impaired activity of natural killer (NK) cells has been proposed as a mechanism contributing to viral persistence in hepatitis C virus (HCV)…”
Get full text

Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening by Hüneburg, R, Lammert, F, Rabe, C, Rahner, N, Kahl, P, Büttner, R, Propping, P, Sauerbruch, T, Lamberti, C

“…Individuals carrying germline mutations in one of the genes responsible for hereditary nonpolyposis colon cancer (HNPCC) have a lifetime risk of up to 80 % of…”
Get more information

Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis by Nischalke, H.D, Berger, C, Aldenhoff, K, Thyssen, L, Gentemann, M, Grünhage, F, Lammert, F, Nattermann, J, Sauerbruch, T, Spengler, U, Appenrodt, B

“…Background & Aims Toll-like receptor (TLR) 2 and nucleotide-binding oligomerisation domain (NOD) 2 recognize distinct pathogen-associated molecular patterns…”
Get full text

Comparison of capsule endoscopy and magnetic resonance imaging for the detection of polyps of the small intestine in patients with familial adenomatous polyposis or with Peutz-Jeghers' syndrome by Caspari, R, von Falkenhausen, M, Krautmacher, C, Schild, H, Heller, J, Sauerbruch, T

“…We have conducted a study to compare the diagnostic yields of magnetic resonance imaging (MRI) and capsule endoscopy for the detection of small-bowel polyps in…”
Get more information

Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis by Hennenberg, M, Trebicka, J, Stark, C, Kohistani, AZ, Heller, J, Sauerbruch, T

“…Background and purpose:  Extrahepatic vasodilation and increased intrahepatic vascular resistance represent attractive targets for the medical treatment of…”
Get full text

Cystatin C-based calculation of glomerular filtration rate in kidney transplant recipients by Pöge, U., Gerhardt, T., Stoffel-Wagner, B., Palmedo, H., Klehr, H.U., Sauerbruch, T., Woitas, R.P.

“…Cystatin C (Cys C) has been shown to be an alternative marker of renal function. However, estimation of the glomerular filtration rate (GFR) based on Cys C has…”
Get full text

Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis by Zhou, Q, Hennenberg, M, Trebicka, J, Jochem, K, Leifeld, L, Biecker, E, Sauerbruch, T, Heller, J

“…Background and aims: Portal hypertension in cirrhosis is mediated in part by increased intrahepatic resistance, reflecting an increased sensitivity of the…”
Get full text

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study by Brensing, K A, Textor, J, Perz, J, Schiedermaier, P, Raab, P, Strunk, H, Klehr, H U, Kramer, H J, Spengler, U, Schild, H, Sauerbruch, T

“…BACKGROUND Recent small studies on hepatorenal syndrome (HRS) indicate some clinical benefit after transjugular intrahepatic portosystemic stent-shunt (TIPS)…”
Get full text

P17 AN ORAL mas-RECEPTOR AGONIST DECREASES PORTAL PRESSURE by Klein, S, Uschner, F.E, Schierwagen, R, Masing, N, Stratëburg, C, Sauerbruch, T, Trebicka, J

Get full text

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine by ZISKE, C, SCHLIE, C, GORSCHLÜTER, M, GLASMACHER, A, MEY, U, STREHL, J, SAUERBRUCH, T, SCHMIDT-WOLF, I. G. H

“…Serum carbohydrate antigen 19-9 (CA 19-9) has been identified as a useful tumour marker for diagnosis of exocrine pancreatic carcinoma, but its value for…”
Get full text

303 PLASMINOGEN K1-5 STRONGLY DECREASES INTRAHEPATIC SPREAD AND TUMOUR GROWTH IN AN EXPERIMENTAL MOUSE FIBROSIS MODEL by Raskopf, E, Sauerbruch, T, Schmitz, V

Get full text

G11 : Microbial translocation in liver fibrosis induces chronic IFNAR signaling that impairs innate immunity against bacterial infection by Abdullah, Z, Hackstein, P, Beyer, M, Trebicka, J, Sauerbruch, T, Spengler, U, Schultze, J.L, Kurts, C, Kastenmüller, W, Knolle, P.A

Get full text

Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS by Nielsen, M. J., Lehmann, J., Leeming, D. J., Schierwagen, R., Klein, S., Jansen, C., Strassburg, C. P., Bendtsen, F., Møller, S., Sauerbruch, T., Karsdal, M. A., Krag, A., Trebicka, J.

“…Background and Aims Progressive fibrosis increases hepatic resistance and causes portal hypertension with complications. During progressive fibrosis remodeling…”
Get full text

Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction by Moleda, Lukas, Trebicka, Jonel, Dietrich, Peter, Gäbele, Erwin, Hellerbrand, Claus, Straub, Rainer H, Sauerbruch, Tilman, Schoelmerich, Juergen, Wiest, Reiner

“…Splanchnic vasodilation triggers the development of the hyperdynamic circulatory syndrome in portal hypertension. Neuropeptide Y (NPY), a sympathetic…”
Get more information

Calculation of glomerular filtration rate based on Cystatin C in cirrhotic patients by Pöge, U., Gerhardt, T., Stoffel-Wagner, B., Klehr, H. U., Sauerbruch, T., Woitas, R. P.

“…Background. Plasma creatinine and creatinine clearance are of limited value for the estimation of renal function in cirrhotics. In these patients, cystatin C…”
Get full text

Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo by Nagaraj, S, Ziske, C, Strehl, J, Messmer, D, Sauerbruch, T, Schmidt-Wolf, IGH

“…Ductal pancreatic adenocarcinoma is the fourth leading cause of cancer death in the Western world. Unfortunately, recent advances in diagnostics, staging and…”
Get full text

Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma by Höblinger, Aksana, Gerhardt, T, Gonzalez-Carmona, M A, Hüneburg, R, Sauerbruch, T, Schmitz, V

“…PDT is an important palliative option for patients with unresectable extrahepatic cholangiocarcinoma (CC). However, the results published to date reported on…”
Get full text

Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer by Hoblinger, A, Grunhage, F, Sauerbruch, T, Lammert, F

“…Multidrug resistance-associated protein 2 (MRP2/ABCC2) is one of the ATP-binding cassette (ABC) transporters expressed on the apical membrane of hepatocytes…”
Get more information

395 COX-2 DRIVES THE SELECTIVE INDUCTION OF APOPTOSIS BY THE ENDOCANNABINOID 2-ARACHIDONOYL GLYCEROL IN HEPATIC STELLATE CELLS by Siegmund, S.V, Wojtalla, A, Schlosser, M, Sauerbruch, T, Singer, M.V

Get full text